Start your own journey to clinic

Please provide us with a few details so that we can match you with the right expert in your field.

*Required

Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at webenquiries@conceptlifesciences.com

Cell Lines

Embrace the efficiency and versatility of cell line-based assays, where immortalized cell lines serve as versatile models for a wide range of applications throughout the drug discovery process. Cell line-based assays offer consistency and reproducibility, ensuring reliability in experimental outcomes. These features, combined with their scalability and cost effectiveness, make them the ideal choice for high-throughput screening, accelerating research by reducing costs and variability.

Connected servicesMore informationSpeak to an expert

Connected expertise and services

A more in-depth view

 

We have extensive experience of culturing a broad variety of  cell lines, and can offer:

  •     Instant access to a diverse inventory of cell lines  representing various cancers and tissues (e.g., skin, lung, liver, pancreas,  brain).
  •     Ability to source cell lines from commercial vendors based on  project requirements.

 

We offer expertise in tissue culture  and assay design:

  •    Skilled tissue culture and cell biologist experts to design,  conduct, and interpret assays using selected methodologies and  instrumentation.
  •     Proficient handling of multiple cell lines concurrently, ideal  for substantial projects when your team's capacity is limited.

 

Examples of work conducted using  cell lines:

  • Compound impact and transcriptomics  analysis: Assessing compound effects on cell viability, apoptosis, and  proliferation, coupled with downstream transcriptomics analysis, beneficial  for drug repositioning studies.
  •    Evaluation in 3D spheroid cultures:  Comparing novel therapies in 3D spheroid cultures versus 2D cultures for more  accurate in vivo efficacy modelling.
  •     Immuno-oncology assays:  Assessing compounds for direct and indirect impacts on cancer cell growth and  metastasis through T cell and NK cell-mediated tumour cell killing,  efferocytosis, and phagocytosis.
  •   Cell migration assessment:  Evaluating compound impact on cell migration using assays mimicking cancer  metastasis and skin epithelization, like the Epithelial to Mesenchymal  Transition assay.
  •    Genetic manipulation for target  validation: Performing genetic manipulation to express or knock down targets  for validation studies.
  •    CNS function and disease modelling:  Utilizing CNS cell lines to assess candidate therapeutics for their ability  to modulate neuroinflammatory responses, functional phenotypes and  disease-associated phenotypes.  

Connected resources